GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » US Neurosurgical Holding Inc (OTCPK:USNU) » Definitions » EV-to-FCF

USNU (US Neurosurgical Holding) EV-to-FCF : -9.52 (As of Mar. 17, 2025)


View and export this data going back to . Start your Free Trial

What is US Neurosurgical Holding EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, US Neurosurgical Holding's Enterprise Value is $12.45 Mil. US Neurosurgical Holding's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was $-1.31 Mil. Therefore, US Neurosurgical Holding's EV-to-FCF for today is -9.52.

The historical rank and industry rank for US Neurosurgical Holding's EV-to-FCF or its related term are showing as below:

USNU' s EV-to-FCF Range Over the Past 10 Years
Min: -14.04   Med: 0.98   Max: 73.31
Current: -9.52

During the past 13 years, the highest EV-to-FCF of US Neurosurgical Holding was 73.31. The lowest was -14.04. And the median was 0.98.

USNU's EV-to-FCF is ranked worse than
100% of 397 companies
in the Healthcare Providers & Services industry
Industry Median: 17.43 vs USNU: -9.52

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-17), US Neurosurgical Holding's stock price is $0.895. US Neurosurgical Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.090. Therefore, US Neurosurgical Holding's PE Ratio (TTM) for today is At Loss.


US Neurosurgical Holding EV-to-FCF Historical Data

The historical data trend for US Neurosurgical Holding's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

US Neurosurgical Holding EV-to-FCF Chart

US Neurosurgical Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 -0.24 0.76 0.31 -4.26

US Neurosurgical Holding Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.42 -4.26 -7.46 -6.43 -5.07

Competitive Comparison of US Neurosurgical Holding's EV-to-FCF

For the Medical Care Facilities subindustry, US Neurosurgical Holding's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


US Neurosurgical Holding's EV-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, US Neurosurgical Holding's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where US Neurosurgical Holding's EV-to-FCF falls into.



US Neurosurgical Holding EV-to-FCF Calculation

US Neurosurgical Holding's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=12.454/-1.308
=-9.52

US Neurosurgical Holding's current Enterprise Value is $12.45 Mil.
US Neurosurgical Holding's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


US Neurosurgical Holding  (OTCPK:USNU) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

US Neurosurgical Holding's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.895/-0.090
=At Loss

US Neurosurgical Holding's share price for today is $0.895.
US Neurosurgical Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.090.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


US Neurosurgical Holding EV-to-FCF Related Terms

Thank you for viewing the detailed overview of US Neurosurgical Holding's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


US Neurosurgical Holding Business Description

Traded in Other Exchanges
N/A
Address
1131 W 6th Street, Ontario, CA, USA, 91672
US Neurosurgical Holding Inc operates as a holding company in the United States. It is a medical services company that partners with hospitals and physicians to operate facilities utilizing artistic and inventive technologies in medical treatment and diagnosis. It is engaged in providing medical treatment and diagnosis services that include stereotactic radiosurgery centers, utilizing gamma knife technology, and holds interests in radiological treatment facilities. The company is focusing on establishing cancer centers using intensity-modulated radiation therapy. Its gamma knife is a stereotactic radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery.
Executives
Lawrence William St director 23 ASHLAND STREET, NEWBURYPORT MA 01950-1905
William F. Leimkuhler director 43 SALEM STRAITS RD, DARIEN CT 06820
Merriman Charles H Iii director
Alan Gold director, 10 percent owner, officer: President & Chairman 2400 RESEARCH BLVD, SUITE 325, ROCKVILLE MD 20850
Stanley S Shuman 10 percent owner C/O RIPPLEWOOD HOLDINGS LLC, ONE ROCKERFELLER PLAZA, NEW YORK NY 10020
Allen & Co Inc 10 percent owner 711 FIFTH AVENUE, NEW YORK NY 10022

US Neurosurgical Holding Headlines

No Headlines